Matrix marker model and methods for assessing and treating arthritis and related disorders
OwnerChenglong Han, Wim Noel +1inventors
InventorsChenglong Han, Wim Noel, Nathan Vastesaeger
Life of this patent
Estimating the term…
Loading patent…
OwnerChenglong Han, Wim Noel +1inventors
InventorsChenglong Han, Wim Noel, Nathan Vastesaeger
Estimating the term…
The invention relates to a method of determining the efficacy of the treatment for RA based on two to several characteristics known to correlate with negative outcomes in RA presented in a matrix, as well as a method of determining the efficacy of the treatment for RA based on preparing matrix table comprising two to several covariates which significantly correlate with radiological progression, where the matrix relates this profile of characteristics or covariates to the probability (risk) of negative outcomes under each of the alternative potential treatments, which can be done for a subject, for example, prior to the manifestation of other gross measurements of clinical response.
A method for prognostic or diagnostic assessment of treatment of a rheumatoid arthritis (RA)related disorder in a subject, comprising:
The method of claim 6, wherein said antirheumatic is selected from methotrexate, auranofin, aurothioglucose, azathioprine, gold sodium thiomalate, hydroxychloroquine sulfate, leflunomide, and sulfasalzine.
A method for prognostic or diagnostic assessment or treatment of a rheumatoid arthritis related disorder in a subject, comprising:
(canceled)
Dependencies are inferred from the claim text.